Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.

Witte J, Mehlis K, Surmann B, Lingnau R, Damm O, Greiner W, Winkler EC (2019)
Annals of oncology : official journal of the European Society for Medical Oncology 30(7): 1061-1070.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Witte, JulianUniBi; Mehlis, Katja; Surmann, BastianUniBi ; Lingnau, Ruth; Damm, OliverUniBi; Greiner, WolfgangUniBi; Winkler, Eva C.
Abstract / Bemerkung
BACKGROUND: Patients experiencing financial distress as a side effect of cancer are not only reported in the US, but also in third-party payer healthcare systems in Europe. Since validated survey instruments are a prerequisite for robust and comparable results, we aimed to compile and classify available instruments to enable both a better understanding of the underlying construct of financial toxicity and to facilitate further studies that are adjustable to various healthcare systems.; MATERIALS AND METHODS: We did a systematic literature search on studies that provide data on perceived cancer-related financial distress experienced by adult patients using PubMed, CINAHL and Web of Science databases up to 2018. We analyzed all detected instruments, items domains and questions with regard to their wording, scales and the domains of financial distress covered.; RESULTS: Among 3,298 records screened, 41 publications based on 40 studies matched our inclusion criteria. Based on the analysis of 352 different questions we identified six relevant subdomains that represent perceptions of and reactions to experienced financial distress: (1) active financial spending, (2) use of passive financial resources, (3) psychosocial responses, (4) support seeking, (5) coping with care or (6) coping with ones' lifestyle. We found an inconsistent coverage and use of these domains that makes it difficult to compare and quantify the prevalence of financial distress. Moreover, some existing instruments do not reflect relevant domains for patients in third-party payer systems.; CONCLUSIONS: There is neither a consistent understanding of the construct of financial burden nor do available instruments cover all relevant aspects of a patients' distress perception. We encourage using the identified six domains to further develop survey instruments and adjust them to different health systems. © The Author 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
Erscheinungsjahr
2019
Zeitschriftentitel
Annals of oncology : official journal of the European Society for Medical Oncology
Band
30
Ausgabe
7
Seite(n)
1061-1070
ISSN
0923-7534
eISSN
1569-8041
Page URI
https://pub.uni-bielefeld.de/record/2935652

Zitieren

Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Annals of oncology : official journal of the European Society for Medical Oncology. 2019;30(7):1061-1070.
Witte, J., Mehlis, K., Surmann, B., Lingnau, R., Damm, O., Greiner, W., & Winkler, E. C. (2019). Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Annals of oncology : official journal of the European Society for Medical Oncology, 30(7), 1061-1070. doi:10.1093/annonc/mdz140
Witte, J., Mehlis, K., Surmann, B., Lingnau, R., Damm, O., Greiner, W., and Winkler, E. C. (2019). Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Annals of oncology : official journal of the European Society for Medical Oncology 30, 1061-1070.
Witte, J., et al., 2019. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Annals of oncology : official journal of the European Society for Medical Oncology, 30(7), p 1061-1070.
J. Witte, et al., “Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.”, Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, 2019, pp. 1061-1070.
Witte, J., Mehlis, K., Surmann, B., Lingnau, R., Damm, O., Greiner, W., Winkler, E.C.: Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1061-1070 (2019).
Witte, Julian, Mehlis, Katja, Surmann, Bastian, Lingnau, Ruth, Damm, Oliver, Greiner, Wolfgang, and Winkler, Eva C. “Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.”. Annals of oncology : official journal of the European Society for Medical Oncology 30.7 (2019): 1061-1070.

76 References

Daten bereitgestellt von Europe PubMed Central.

End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes?
McGuire A, Drummond M, Martin M, Justo N., Expert Rev Pharmacoecon Outcomes Res 15(4), 2015
PMID: 26176751
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011.
Shih YC, Smieliauskas F, Geynisman DM, Kelly RJ, Smith TJ., J. Clin. Oncol. 33(19), 2015
PMID: 25987701
Financial strain over the life course and health among older adults.
Kahn JR, Pearlin LI., J Health Soc Behav 47(1), 2006
PMID: 16583773
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.
Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP., Oncologist 18(4), 2013
PMID: 23442307
Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer.
Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D., J. Clin. Oncol. 34(15), 2016
PMID: 26926678
Financial insolvency as a risk factor for early mortality among patients with cancer
Ramsey SD, Bansal A, Fedorenko CR., 2016
Financial stress and strain associated with terminal cancer--a review of the evidence.
Hanratty B, Holland P, Jacoby A, Whitehead M., Palliat Med 21(7), 2007
PMID: 17942498
A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.
Gordon LG, Merollini KMD, Lowe A, Chan RJ., Patient 10(3), 2017
PMID: 27798816
Financial Hardships Experienced by Cancer Survivors: A Systematic Review.
Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR., J. Natl. Cancer Inst. 109(2), 2016
PMID: 27754926
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.
Perrone F, Jommi C, Di Maio M, Gimigliano A, Gridelli C, Pignata S, Ciardiello F, Nuzzo F, de Matteis A, Del Mastro L, Bryce J, Daniele G, Morabito A, Piccirillo MC, Rocco G, Guizzaro L, Gallo C., Ann. Oncol. 27(12), 2016
PMID: 27789469
Financial toxicity in cancer patients: impact of a chronic disease on patients’ economic situation and psychosocial outcomes
Mehlis K, Witte J, Surmann B., 2018
Financial distress in patients with advanced cancer.
Barbaret C, Brosse C, Rhondali W, Ruer M, Monsarrat L, Michaud P, Schott AM, Delgado-Guay M, Bruera E, Sanchez S, Filbet M., PLoS ONE 12(5), 2017
PMID: 28545063
What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups.
Martin MY, Fouad MN, Oster RA, Schrag D, Urmie J, Sanders S, Pisu M., Support Care Cancer 22(1), 2013
PMID: 24037412
Cost of cancer care: issues and implications.
Meropol NJ, Schulman KA., J. Clin. Oncol. 25(2), 2007
PMID: 17210937
The personal financial burden of complications after colorectal cancer surgery.
Regenbogen SE, Veenstra CM, Hawley ST, Banerjee M, Ward KC, Kato I, Morris AM., Cancer 120(19), 2014
PMID: 24889014
A composite measure of personal financial burden among patients with stage III colorectal cancer.
Veenstra CM, Regenbogen SE, Hawley ST, Griggs JJ, Banerjee M, Kato I, Ward KC, Morris AM., Med Care 52(11), 2014
PMID: 25304021
Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life.
Rogers SN, Harvey-Woodworth CN, Hare J, Leong P, Lowe D., Br J Oral Maxillofac Surg 50(5), 2011
PMID: 22000023
Determinants of Patient-Centered Financial Stress in Patients With Locally Advanced Head and Neck Cancer.
de Souza JA, Kung S, O'Connor J, Yap BJ., J Oncol Pract 13(4), 2017
PMID: 28195811
Financial catastrophe, treatment discontinuation and death associated with surgically operable cancer in South-East Asia: Results from the ACTION Study.
ACTION Study Group, Jan S, Kimman M, Peters SA, Woodward M, Woodward M, Jan S, Kimman M, Kingston D, Sokha E, Thabrany H, Bounxouei B, Bhoo-Pathy N, Khin M, Cristal-Luna G, Khuhaprema T, Hung NC, Arounlangsy P, Aung S, Balete SL, Khuayjarernpanishk T, Bhoo-Pathy N, Bounxouei B, Bui D, Datukan J, Gorospe AE, Yip CH, Khopaibul P, Khuhaprema T, Khin M, Klinwimol T, Lalitwongsa S, Lawbundis D, Lola C, Marbella L, Trong KM, Maung SO, Mon S, Naing WP, Ngelangel CA, Nyein HL, Ong-Cornel AB, Oo KM, Orolfo-Real I, Xuan DP, Pharin S, Pujianto , Rattanavong O, Samnang K, Sangkittipaiboon S, Sangrajrang S, Santiago-Ferreras C, Shwe S, Sokha E, Sinthusake T, Suanplu D, Tanabodee J, Thabrany H, Thepsuwan K, Tun YY, Viroath H, Win le L, Win SS, Win TM, Monaghan H, Ashariati A, Atmakusuma D, Bakta IM, Kim LD, Ngoc PD, Bao TD, Djatmiko A, Fachruddin A, Kurnianda J, Muthalib A, Thuy TN, Hoang TN, Hoai NN, Panigoro SS, Quang HP, Pin GP, Thanh KQ, Sarnianto P, Suardi DR, Dinh HT, Subramaniam S, Sudoyo AW, Dang KT, Suharti C., Surgery 157(6), 2015
PMID: 25934082
Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress.
Nipp RD, Zullig LL, Samsa G, Peppercorn JM, Schrag D, Taylor DH Jr, Abernethy AP, Zafar SY., Psychooncology 25(6), 2015
PMID: 26149817
Economic stress among low-income women with cancer: effects on quality of life.
Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee PJ, Vourlekis B., Cancer 112(3), 2008
PMID: 18085642
Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer.
Zullig LL, Peppercorn JM, Schrag D, Taylor DH Jr, Lu Y, Samsa G, Abernethy AP, Zafar SY., J Oncol Pract 9(6S), 2013
PMID: 29431038
Family and out-of-pocket costs for women with breast cancer.
Given BA, Given CW, Stommel M., Cancer Pract 2(3), 1994
PMID: 8055022
Does economic burden influence quality of life in breast cancer survivors?
Meneses K, Azuero A, Hassey L, McNees P, Pisu M., Gynecol. Oncol. 124(3), 2011
PMID: 22138013
InCharge financial distress/financial well-being scale: development, administration, and score interpretation
Prawitz AD, Garman ET, Sorhaindo B., 2006
Patient Attitudes Regarding the Cost of Illness in Cancer Care.
Meisenberg BR, Varner A, Ellis E, Ebner S, Moxley J, Siegrist E, Weng D., Oncologist 20(10), 2015
PMID: 26330457
Financial distress and its predicting factors among iranian cancer patients.
Fathollahzade A, Rahmani A, Dadashzadeh A, Gahramanian A, Esfahani A, Javanganji L, Nabiolahi L., Asian Pac. J. Cancer Prev. 16(4), 2015
PMID: 25743842
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer.
Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, Plimack ER, Martin LP, von Mehren M, Lewis B, Wong YN., J Oncol Pract 12(7), 2016
PMID: 27328795
The development of a financial toxicity patient-reported outcome in cancer: The COST measure.
de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty CK., Cancer 120(20), 2014
PMID: 24954526
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, Hlubocky FJ, Nicholas LH, O'Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella D., Cancer 123(3), 2016
PMID: 27716900
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA., Lancet Haematol 2(10), 2015
PMID: 26686042
Financial burden in recipients of allogeneic hematopoietic cell transplantation.
Khera N, Chang YH, Hashmi S, Slack J, Beebe T, Roy V, Noel P, Fauble V, Sproat L, Tilburt J, Leis JF, Mikhael J., Biol. Blood Marrow Transplant. 20(9), 2014
PMID: 24867778
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC., J. Natl. Cancer Inst. 85(5), 1993
PMID: 8433390
A modular approach to quality-of-life assessment in cancer clinical trials.
Aaronson NK, Bullinger M, Ahmedzai S., Recent Results Cancer Res. 111(), 1988
PMID: 2459750

Marshall GN, Hays RD.., 1994
Self-reported financial burden and satisfaction with care among patients with cancer.
Chino F, Peppercorn J, Taylor DH Jr, Lu Y, Samsa G, Abernethy AP, Zafar SY., Oncologist 19(4), 2014
PMID: 24668333
The Social Difficulties Inventory (SDI): development of subscales and scoring guidance for staff.
Wright P, Smith AB, Keding A, Velikova G., Psychooncology 20(1), 2011
PMID: 20186841
Development and evaluation of an instrument to assess social difficulties in routine oncology practice.
Wright EP, Kiely M, Johnston C, Smith AB, Cull A, Selby PJ., Qual Life Res 14(2), 2005
PMID: 15892426
Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey.
Malin JL, Ko C, Ayanian JZ, Harrington D, Nerenz DR, Kahn KL, Ganther-Urmie J, Catalano PJ, Zaslavsky AM, Wallace RB, Guadagnoli E, Arora NK, Roudier MD, Ganz PA., Support Care Cancer 14(8), 2006
PMID: 16482448
Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer?
Pisu M, Kenzik KM, Oster RA, Drentea P, Ashing KT, Fouad M, Martin MY., Cancer 121(8), 2015
PMID: 25564986
Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study.
Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D., J Oncol Pract 11(2), 2014
PMID: 25515717
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis
Shankaran V, Jolly S, Blough D, Ramsey SD.., 2012
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.
Abel GA, Albelda R, Khera N, Hahn T, Salas Coronado DY, Odejide OO, Bona K, Tucker-Seeley R, Soiffer R., Biol. Blood Marrow Transplant. 22(8), 2016
PMID: 27184627
Financial burden among US households affected by cancer at the end of life.
Cagle JG, Carr DC, Hong S, Zimmerman S., Psychooncology 25(8), 2015
PMID: 26282448
Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients.
Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, Tayjasanant S, Ochoa J, Cantu H, Chisholm G, Williams J, Frisbee-Hume S, Bruera E., Oncologist 20(9), 2015
PMID: 26205738
Impact of financial burden of cancer on survivors' quality of life.
Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, Hofstatter EW, Killelea BK, Knobf MT, Lannin DR, Abu-Khalaf M, Horowitz NR, Chagpar AB., J Oncol Pract 10(5), 2014
PMID: 24865220
Personal financial effects of multiple myeloma and its treatment.
Goodwin JA, Coleman EA, Sullivan E, Easley R, McNatt PK, Chowdhury N, Stewart CB., Cancer Nurs 36(4), 2013
PMID: 23047800
Exploring the economic impact of breast cancers during the 18 months following diagnosis.
Gordon L, Scuffham P, Hayes S, Newman B., Psychooncology 16(12), 2007
PMID: 17345557
Financial toxicity: a potential side effect of prostate cancer treatment among Australian men
Gordon LG, Walker SM, Mervin MC., 2017
Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries
Jagsi R, Pottow JAE, Griffith KA., 2014
Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?
Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, Rowland JH., Cancer 119(20), 2013
PMID: 23907958
Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey.
Kodama Y, Morozumi R, Matsumura T, Kishi Y, Murashige N, Tanaka Y, Takita M, Hatanaka N, Kusumi E, Kami M, Matsui A., BMC Cancer 12(), 2012
PMID: 22530992
Financial and family burden associated with cancer treatment in Ontario, Canada.
Longo CJ, Fitch M, Deber RB, Williams AP., Support Care Cancer 14(11), 2006
PMID: 16896878
An examination of cancer patients' monthly ‘out-of-pocket’ costs in Ontario, Canada
Longo CJ, Deber R, Fitch M., 2007
The economic consequences of breast cancer adjuvant hormonal treatments
Pezzin LE, O’Niel MB, Nattinger AB.., 2009
Predictors of financial difficulties and work modifications among cancer survivors in the United States.
Whitney RL, Bell JF, Reed SC, Lash R, Bold RJ, Kim KK, Davis A, Copenhaver D, Joseph JG., J Cancer Surviv 10(2), 2015
PMID: 26188363
Financial hardship associated with cancer in the United States: findings From a population-based sample of adult cancer survivors
Yabroff KR, Dowling EC, Guy GP., 2016

AUTHOR UNKNOWN, 0
Krebs und Armut
Walther J.., 2011
Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers.
Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL., Ann. Intern. Med. 132(6), 2000
PMID: 10733444
A tale of two continents: insuring workers against loss of income due to sickness in North America and Europe
Treble J.., 2009
Radiation Therapy Noncompliance and Clinical Outcomes in an Urban Academic Cancer Center.
Ohri N, Rapkin BD, Guha C, Kalnicki S, Garg M., Int. J. Radiat. Oncol. Biol. Phys. 95(2), 2016
PMID: 27020104
Comparisons of health care systems in the United States, Germany and Canada.
Ridic G, Gleason S, Ridic O., Mater Sociomed 24(2), 2012
PMID: 23678317

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 31046080
PubMed | Europe PMC

Suchen in

Google Scholar